Newer Dopaminergic Agents Cause Minimal Endocrine Effects in Idiopathic Parkinson’s Disease


OBJECTIVE We studied the prevalence of endocrine dysfunction in subjects with idiopathic Parkinson's disease (IPD) on newer dopaminergic agents (DA). DA are also used in endocrine hypersecretory states in small doses and we hypothesized that endocrine dysfunction was likely in IPD where DA were used in comparatively much higher dosage. PATIENTS AND… (More)
DOI: 10.4137/CMED.S14902


3 Figures and Tables

Slides referencing similar topics